Abstract
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effects of early abiraterone acetate in combination with androgen deprivation therapy for newly diagnosed metastatic hormone-sensitive prostate cancer.
Original language | English (US) |
---|---|
Article number | CD013245 |
Journal | Cochrane Database of Systematic Reviews |
Volume | 2019 |
Issue number | 1 |
DOIs | |
State | Published - Jan 24 2019 |
Bibliographical note
Publisher Copyright:© 2019 The Cochrane Collaboration.